- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05147038
The Impact of Tele-coaching on the Physical Activity Level
The Impact of Tele-coaching on the Physical Activity Level in Patients With Chronic Respiratory Disease
Study Overview
Detailed Description
The level of physical activity (PA) has been shown to be an important predictor for morbidity and mortality in individuals with chronic respiratory diseases, for instance Chronic Obstructive Pulmonary Disease (COPD) or Idiopathic Pulmonary Fibrosis (IPF). Physical inactivity and sedentary behavior is a common feature of patients with chronic respiratory diseases. Pulmonary rehabilitation is known as a beneficial intervention in exercise capacity, disease symptoms and quality of life in respiratory diseases. Despite the overall large benefits on exercise capacity and other variables described above, it does not automatically translate into increases in PA. Recent literature shows that coaching programs specifically aiming to increase PA are more likely to result in PA changes.
Therefore, this study was designed to investigate the impact of 3-month (12 weeks) tele-coaching intervention on PA level of adult participants suffering from a chronic lung disease.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Tamara Zlamalova, MSc.
- Phone Number: +420773898849
- Email: tamara.zlamalova01@upol.cz
Study Locations
-
-
-
Olomouc, Czechia, 77111
- Recruiting
- Faculty of Physical Culture, Palacky University Olomouc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Stable patients, older than 18 years of age, with a diagnosis of interstitial lung disease
- Understands and is able to work with a smart phone application (judged by the investigator)
- On stable pharmacotherapy
- Diffusing capacity of the lungs for carbon monoxide (DLCO) ≥30%predicted
Exclusion Criteria:
- On the waiting list for a lung transplantation
- Life expectancy below 3 months
- Respiratory tract infection or an exacerbation or change in maintenance medication within 4 weeks before study enrolment
- Extra pulmonary impairments, unrelated to the underlying lung disease, interfering with physical activity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
Participants allocated into the intervention group will be coached for 12 weeks by a tele-coaching mobile App containing tips for PA increase and for number of steps recording (visual feedback for the patient).
|
The participants are instructed to use a "Fitbit" fitness tracker to record the number of steps.
This device is compatible with the "m-PAC" App, which was developed for this specific group of participants (individuals suffering from a chronic lung disease).
The participants receive a feedback via the "m-PAC" App every day and they also receive a week report to be albe to adjust their step goal.
They are asked to increase or keep their week goal every Sunday after reviewing a weekly report.
The participants also receive tips for their PA improvement and they are asked for medication change specification (every Wednesday).
|
No Intervention: Control group
Participants in the control group will receive usual care (including regular visits) together with the educational information.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Objective measurement of physical activity
Time Frame: 12 weeks
|
Change in weekly mean step count 12 weeks post randomization in the intervention group as compared to the control group.
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical activity parameters
Time Frame: 12 weeks
|
Objectively measured mean daily time in at least moderate intense activity, walking time, movement intensity and activity bout duration.
|
12 weeks
|
Spirometry 1
Time Frame: 12 weeks
|
Respiratory muscle function 1 (VC = vital capacity, FVC = forced vital capacity, FEV1 = forced expiratory volume at one second [L]).
|
12 weeks
|
Spirometry 2
Time Frame: 12 weeks
|
Respiratory muscle function 2 (PEF = peak expiratory flow [L/min]).
|
12 weeks
|
Spirometry 3
Time Frame: 12 weeks
|
Respiratory muscle strength (MIP = maximum inspiratory pressure, MEP = maximum expiratory pressure, P0.1 = airway occlusion pressure [kPa], TTmus = tension time index).
|
12 weeks
|
Six minute walk test
Time Frame: 12 weeks
|
Functional exercise capacity.
|
12 weeks
|
Isometric Quadriceps force
Time Frame: 12 weeks
|
Isometric Quadriceps strength measurement.
|
12 weeks
|
Questionnaire 1
Time Frame: 12 weeks
|
Health status evaluation: 36-Item Short Form Survey (SF-36).
There are 8 scales.
Each scale is directly transformed into a 0-100 scale (each question carries equal weight).
The lower the score is, the more disability it expresses.
|
12 weeks
|
Questionnaire 2
Time Frame: 12 weeks
|
Interstitial lung disease specific health-related quality of life evaluation: The King's Brief Interstitial Lung Disease (KBILD) questionnaire.
A15-item validated questionnaire.
The total score ranges from 0-100.
There are three domain scores: Psychological, Breathlessness and activities and Chest symptoms.
The higher score reflects better health-related quality of life.
|
12 weeks
|
Questionnaire 3
Time Frame: 12 weeks
|
Anxiety and depression evaluation: Hospital Anxiety and Depression Scale (HADS).
There are 14 items.
The scoring ranges from 0 to 21.
The higher the score, the more severe the anxiety and depression level is.
|
12 weeks
|
Questionnaire 4
Time Frame: 12 weeks
|
Fatigue evaluation: Multidimensional Assessment of Fatigue (MAF) Scale.
It contains 16 items.
Scores range from 1 (no fatigue) to 50 (severe fatigue) and the higher score means worse fatigue.
|
12 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 80/2020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Telemedicine
-
Michigan State UniversityUniversity of Michigan; Wake Forest University Health Sciences; Babes-Bolyai...CompletedUsual Care | Telemedicine: Smoking Cessation App Only | Telemedicine: Smoking Cessation Counseling | Telemedicine: App + CounselingRomania
-
The Hong Kong Polytechnic UniversityCompleted
-
Wake Forest University Health SciencesCompleted
-
Buzzi Children's HospitalCompleted
-
The Hong Kong Polytechnic UniversityCompleted
-
University of MichiganCompleted
-
US Department of Veterans AffairsCompleted
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Naima Health LLCUniversity of Pittsburgh; Obstetrix Medical GroupRecruiting
Clinical Trials on Tele-coaching
-
Boston Children's HospitalJohns Hopkins University; University of Kansas Medical Center; Cystic Fibrosis... and other collaboratorsCompletedCystic FibrosisUnited States
-
Case Western Reserve UniversityCompletedMultiple Sclerosis | CaregiversUnited States
-
Northumbria UniversityNewcastle-upon-Tyne Hospitals NHS TrustUnknownLung Transplant RecipientsUnited Kingdom
-
Pennington Biomedical Research CenterLouisiana State University Health Care Services DivisionCompletedHypertension | Obesity | Diabetes | OverweightUnited States
-
Mayo ClinicPreventiceCompleted
-
University Hospital, GhentHasselt University; Jessa Hospital; AZ Sint-Jan AV; AZ Delta; Ziekenhuis Oost-LimburgRecruitingNon Small Cell Lung Cancer | Non-small Cell CarcinomaBelgium
-
University of TorontoYMCA; Ontario HIV Treatment NetworkCompleted
-
Seoul National University HospitalSeoul National University Bundang Hospital; Korea Health Industry Development... and other collaboratorsCompletedArthritis | Osteoporosis | Osteopenia | Chronic Respiratory DiseaseKorea, Republic of
-
KU LeuvenCompletedInterstitial Lung Disease | Interstitial Pulmonary FibrosisBelgium